Open AccessHerpes simplex virus type 1 infection activates the Epstein–Barr virus replicative cycle via a CREB‐dependent mechanism
Author(s) -
Wu Hongling,
Li Ting,
Zeng Musheng,
Peng Tao
Publication year - 2012
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1111/j.1462-5822.2011.01740.x
Subject(s) - biology , virology , herpes simplex virus , mechanism (biology) , virus , simplexvirus , herpesviridae , viral disease , philosophy , epistemology
Summary The reactivation of latent Epstein–Barr virus (EBV) to lytic replication is important in pathogenesis and requires virus–host cellular interactions. However, the mechanism underlying the reactivation of EBV is not yet fully understood. In the present study, herpes simplex virus type 1 (HSV‐1) was shown to induce the reactivation of latent EBV by triggering BZLF1 expression. The BZLF1 promoter (Zp) was not activated by HSV‐1 essential glycoprotein‐induced membrane fusion. Nevertheless, Zp was activated within 6 h post HSV‐1 infection in virus entry‐dependent and replication‐independent manners. Using a panel of Zp deletion mutants, HSV‐1 was shown to promote Zp through a cyclic adenosine monophosphate (cAMP) response element (CRE) located in ZII. The phosphorylated cAMP response element‐binding (phos‐CREB) protein, the cellular transactivator that binds to CRE, also increased after HSV‐1 infection. By transient transfection, cAMP‐dependent protein kinase A and HSV‐1 US3 protein were found to be capable of activating Zp in CREB‐ and CRE‐dependent manners. The relationship between EBV activation and HSV‐1 infection revealed a possible common mechanism that stimulated latent EBV into lytic cycles in vivo .